EPIDEMIOLOGY OF LARYN'S CANCER IN THE REPUBLIC OF KAZAKHSTAN IN 2008-2017
Relevance. Esophageal cancer (RP), according to Global Cancer Statistics, in 2018, the total number of patients with the first-ever diagnosis was 3.2% in the overall structure of oncological diseases. Mortality from RP amounted to 5.3% in the overall structure of mortality from this disease.
The aim of the study is to analyze the incidence of esophageal cancer, mortality from this disease, as well as morbidity rates among the male and female population in the Republic of Kazakhstan (RK) for the period 2008–2017.
Materials and methods. Forms number 35 Annual, "Report on patients with malignant neoplasms." The incidence, mortality, and average long-term epidemiological indicators for the period 2008-2017 were calculated. The assessment of the dynamics of the studied indicators for the period 2008–2017 was carried out by determining trends - upward or downward. To assess the statistical significance of the obtained trends, the method of univariate linear regression was used.
Results. A statistically significant trend of decreasing the incidence (from 8.2 to 6.8 per 100,000 population) and mortality from esophageal cancer (from 6.9 to 4.3 per 100,000 population) was revealed. During the study period, there was a decrease in incidence rates among the male population in the Republic of Kazakhstan (from 9.4 to 8.0 per 100,000 population). For the female population, the incidence rates also tended to decrease (from 7.6 to 5.6 per 100,000 population).
Findings. During the study period of the years, the epidemiological situation with the RP in the Republic of Kazakhstan has a steady tendency to improvement, but at the same time, the regions of the country differ significantly in both the initial values of the epidemiological indicators and the observed trends in their changes.
Adilbek N. Baimussanov 1,
Adylzhan S. Massadykov 2,
Zukhra S. Siyazbekova 1,
Gulnar M. Shalgumbayeva 3, http://orcid.org/0000-0003-3310-4490
1 Department of Public Health, «Semey Medical University», Semey, Republic of Kazakhstan;
2 "National Center for Independent Examination" in the East Kazakhstan region, Ust-Kamenogorsk, Republic of Kazakhstan;
3 Department of personalized medicine, Semey medical university,
Semey, Republic of Kazakhstan.
1. Гржибовский А.М. Однофакторный линейный регрессионный анализ // Экология человека. 2008. № 10. С. 55–64.
2. Кайбышева В.О. Эпидемиология, факторы риска и профилактика рака пищевода. // Гастроэнтерология. 2012. №6. С.29-33
3. Холматова К.К., Гржибовский А.М. Панельные исследования и исследования тренда в медицине и общественном здравоохранении // Экология человека. 2016. № 10. С. 57–64.
4. Холматова К.К., Харькова О.А., Гржибовский А.М. Классификация научных исследований в здравоохранении // Экология человека. 2016. № 1. С. 57–64
5. Янкин А.В. Рак пищевода: от статистики к диагностике // Практическая онкология. 2003. Т. 4, № 2. С.61-65
6. Arnold M., Laversanne M., Brown L.M., Devesa S.S., Bray F. Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030 // Am J Gastroenterol. 2017;112:1247-1255
7. Blot W.J., Tarone R.E. Esophageal cancer. In: Thun M.J., Linet M.S., Cerhan J.R., Haiman C.A., Schottenfeld D., eds. Cancer Epidemiology and Prevention. 4th ed. New York: Oxford University Press; 2017 2018:579-592
8. Chen et al. Esophageal cancer incidence and mortality in China, 2009 // J Thorac Dis. 2013;5(1):19-26. DOI: 10.3978/j.issn.2072-1439.2013.01.04
9. Domper Arnal M.J. et al. Esophageal cancerRisk factors, screening and endoscopic treatment in Western and Eastern countries // World J Gastroenterol 2015 July 14; 21(26): 7933-7943
10. Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L. Siegel, Lindsey A. Torre, Ahmedin Jemal. Global Cancer Statistics 2018. CA CANCER J CLIN 2018;68:394-424.
11. McCormack V.A., Menya D., Munishi M.O., et al. Informing etiologic research priorities for squamous cell esophageal cancer in Africa: a review of setting-specific exposures to known and putative risk factors. Int J Cancer. 2017;140:259-271
12. Stahl et al. Esophageal cancer: Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2010; Volume 21(Supplement 5):46-49 doi:10.1093/annonc/mdq163
13. Yuwei Zhang. Epidemiology of esophageal cancer. World J Gastroenterol. 2013, September 14; 19(34): 5598-5606
14. Zeng H. et al. Esophageal cancer statistics in China, 2011: Estimates based on 177 cancer registries. Thoracic Cancer. 2016; 7:232–23
References:
1. Grzhibovskij A.M Odnofaktornyi lineinyi regressionnyi analiz [Univariate linear regression analysis]. Ekologiya cheloveka [Human ecology]. 2008. №10. рр. 55-64 [in Russian]
2. Kajbysheva V.O. Epidemiologiya, faktory riska i profilaktika raka pishchevoda [Epidemiology, risk factors and prevention of esophageal cancer]. Gastroenterologiya [Gastroenterology]. 2012. №6. pp.29-33 [in Russian]
3. Kholmatova K.K., Grjibovski A.M. Panel'nye issledovaniya i issledovaniya trenda v meditsine i obshchestvennom zdravookhranenii [Panel- and trend studies in medicine and public health]. Ekologiya cheloveka [Human ecology]. 2016. № 10. pp. 57–64 [in Russian]
4. Holmatova K.K., Har'kova O.A., Grzhibovskij A.M. Klassifikatsiya nauchnykh issledovanii v zdravookhranenii [Types of research in health sciences] Ekologiya cheloveka [Human ecology]. 2016. № 1. pp. 57–64 [in Russian]
5. Yankin A.V. Rak pishchevoda: ot statistiki k diagnostike [Esophageal cancer: from statistics to diagnoses]. Prakticheskaya onkologiya. [Practical oncology]. 2003. T. 4, № 2.pp.61-65 [in Russian]
6. Arnold M., Laversanne M., Brown L.M., Devesa S.S., Bray F. Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030. Am J Gastroenterol. 2017;112:1247-1255
7. Blot W.J., Tarone R.E. Esophageal cancer. In: Thun MJ, Linet MS, Cerhan JR, Haiman CA, Schottenfeld D, eds. Cancer Epidemiology and Prevention. 4th ed. New York: Oxford University Press; 2017 2018:579-592
8. Chen et al. Esophageal cancer incidence and mortality in China, 2009. J Thorac Dis. 2013;5(1):19-26. DOI: 10.3978/j.issn.2072-1439.2013.01.04
9. Domper Arnal M.J. et al. Esophageal cancer Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015 July 14; 21(26): 7933-7943
10. Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L. Siegel, Lindsey A. Torre, Ahmedin Jemal. Global Cancer Statistics 2018. CA CANCER J CLIN 2018;68:394-424.
11. McCormack V.A., Menya D., Munishi M.O., et al. Informing etiologic research priorities for squamous cell esophageal cancer in Africa: a review of setting-specific exposures to known and putative risk factors. Int J Cancer. 2017;140:259-271
12. Stahl et al. Esophageal cancer: Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2010; Volume 21 (Supplement 5):46-49 doi:10.1093/annonc/mdq163
13. Yuwei Zhang. Epidemiology of esophageal cancer. World J Gastroenterol. 2013, September 14; 19(34): 5598-5606
14. Zeng H. et al. Esophageal cancer statistics in China, 2011: Estimates based on 177 cancer registries. Thoracic Cancer. 2016; 7:232–23
Number of Views: 300
Category of articles:
Original articles
Bibliography link
Баймусанов А.Н., Масадыков А.С., Сиязбекова З.С., Шалгумбаева Г.М. Эпидемиология рака пищевода в Республике Казахстан в 2008-2017 годах // Наука и Здравоохранение. 2019. 2 (Т.21).С. 83-90. Baimussanov A.N., Massadykov A.S., Siyazbekova Z.S., Shalgumbayeva G.M. Epidemiology of esophageal cancer in the Republic of Kazakhstan in 2008-2017 // Nauka i Zdravookhranenie [Science & Healthcare]. 2019, (Vol.21) 2, pp. 83-90. Баймусанов А.Н., Масадыков А.С., Сиязбекова З.С., Шалгумбаева Г.М. 2008-2017 жж. Қазақстан Республикасында өңеш обырының эпидемиологиясы // Ғылым және Денсаулық сақтау. 2019. 2 (Т.21). Б. 83-90.Related publications:
ANALYSIS OF CLINICAL AND DEMOGRAPHIC INDICATORS OF PATIENTS WITH PARKINSON'S DISEASE IN THE SOUTHERN REGION OF KAZAKHSTAN
A COMPARATIVE STUDY OF DRUG POLICY REGARDING ORPHAN DISEASES IN THE USA, THE EUROPEAN UNION, AND THE REPUBLIC OF KAZAKHSTAN
MUTATIONS IN CARDIAC ION CHANNEL GENES IN KAZAKHSTANI PATIENTS WITH LONG QT SYNDROME
GENETIC FEATURES OF CONGENITAL DYSFUNCTION OF THE ADRENAL CORTEX CAUSED BY 21-HYDROXYLASE DEFICIENCY IN PERSONS OF KAZAKH NATIONALITY
NON-MOTOR SYMPTOMS IN PARKINSON'S DISEASE USING THE EXAMPLE OF AKTOBE PATIENTS